Moderna Inc and Swiss contract drugmaker Lonza Group AG said on Friday they would accelerate the manufacturing of the U.S. drug developer’s potential...

An improved manufacturing process has made it possible to reduce the CV (coefficient of variation) of the pneumatically pumped liquid volumes to ≤ 6%

Moderna Therapeutics’ modified mRNA vaccine for COVID-19 began phase 1 clinical testing. From the first description of the novel coronavirus...

CureVac AG, a clinical stage biopharmaceutical company pioneering mRNA-based drugs for vaccines and therapeutics, confirmed today that internal...

The iGEM team Aachen 2019 was nominated for the category of "Best Environment Project”, and won a gold medal for completing their project.

This year, for the seventh consecutive year, a team from m2p-labs participated again at the local running event, the so called “Aachener Firmenlauf”....